171 related articles for article (PubMed ID: 2587969)
1. [Visceral leishmaniasis (kala-azar) as an opportunistic infection in immunosuppressed patients].
Lüthy RM; Kistler HJ
Schweiz Med Wochenschr; 1989 Sep; 119(38):1309-13. PubMed ID: 2587969
[TBL] [Abstract][Full Text] [Related]
2. Visceral leishmaniasis (kala azar) in a patient with AIDS.
Smith D; Gazzard B; Lindley RP; Darwish A; Reed C; Bryceson AD; Evans DA
AIDS; 1989 Jan; 3(1):41-3. PubMed ID: 2496712
[TBL] [Abstract][Full Text] [Related]
3. [Visceral leishmaniasis (kala-azar) and HIV infection. Apropos of a case and literature review].
Joggi J; Chave JP; Bruni D; Schmidt PM
Schweiz Med Wochenschr; 1990 Mar; 120(12):414-6. PubMed ID: 2181645
[TBL] [Abstract][Full Text] [Related]
4. Disseminated visceral leishmaniasis (kala azar) in acquired immunodeficiency syndrome (AIDS).
Falk S; Helm EB; Hübner K; Stutte HJ
Pathol Res Pract; 1988 Jun; 183(3):253-5. PubMed ID: 3420026
[TBL] [Abstract][Full Text] [Related]
5. [Cutaneo-visceral leishmaniasis: a new opportunistic infection in patients infected by HIV].
Botella Estrada R; Sanmartín Jiménez O; Febrer Bosch MI; Aliaga Boniche A; Salavert Lleti M; Roig Rico P; Nieto García A; Navarro Ibañez V
Med Cutan Ibero Lat Am; 1990; 18(2):119-23. PubMed ID: 2214938
[TBL] [Abstract][Full Text] [Related]
6. Kala-azar comes to New York.
Parkas V; Godwin J; Murray HW
Arch Intern Med; 1997 Apr; 157(8):921-3. PubMed ID: 9129553
[TBL] [Abstract][Full Text] [Related]
7. [Visceral leishmaniasis and AIDS. Report of 2 cases with cutaneous dissemination].
Belda Mira A; Díaz Sánchez F; Martínez García B; Gonzalvo Bellver E; Antón Crespo V; Redón Mas J
An Med Interna; 1994 Aug; 11(8):398-400. PubMed ID: 7772689
[TBL] [Abstract][Full Text] [Related]
8. [3 cases of visceral leishmaniasis, one in a HIV-positive man].
Balslev U; Jonsbo F; Junge J; Bentsen KD
Ugeskr Laeger; 1991 May; 153(22):1591-2. PubMed ID: 2058021
[TBL] [Abstract][Full Text] [Related]
9. Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome.
Antinori S; Longhi E; Bestetti G; Piolini R; Acquaviva V; Foschi A; Trovati S; Parravicini C; Corbellino M; Meroni L
Br J Dermatol; 2007 Nov; 157(5):1032-6. PubMed ID: 17854365
[TBL] [Abstract][Full Text] [Related]
10. Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome.
Curry JL; Prieto VG; Jones DM; Vega F; Duvic M; Diwan AH
J Cutan Pathol; 2011 Mar; 38(3):295-7. PubMed ID: 19889052
[TBL] [Abstract][Full Text] [Related]
11. [Unsuspected visceral leishmaniasis infiltrating a squamous cell carcinoma].
Armengot-Carbó M; Carmena-Ramón R; Rodrigo-Nicolás B; Ferrando-Marco J
Actas Dermosifiliogr; 2012 May; 103(4):321-3. PubMed ID: 21885024
[TBL] [Abstract][Full Text] [Related]
12. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
[TBL] [Abstract][Full Text] [Related]
13. [Visceral leishmaniasis and immunosuppression].
Lortholary O; Christiaens D; Mechali D; Babinet P
Ann Med Interne (Paris); 1991; 142(3):215-7. PubMed ID: 1854134
[No Abstract] [Full Text] [Related]
14. Visceral kala-azar associated with post-kala-azar dermal leishmaniasis.
Singh NK; Agrawal SK; Jha TK
J Assoc Physicians India; 1989 Feb; 37(2):191. PubMed ID: 2808294
[TBL] [Abstract][Full Text] [Related]
15. Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS.
Calza L; D'Antuono A; Marinacci G; Manfredi R; Colangeli V; Passarini B; Orioli R; Varoli O; Chiodo F
J Am Acad Dermatol; 2004 Mar; 50(3):461-5. PubMed ID: 14988693
[TBL] [Abstract][Full Text] [Related]
16. [Visceral leishmaniasis in Alicante. Analysis of 21 cases].
Portilla Sogorb J; Rosas Gómez de Salazar JC; Casellas Valde JA; Abad Gosálbez A; Monpel Sanjuan A; Palmero Cabezas MF
Rev Clin Esp; 1990 Jun; 187(2):53-5. PubMed ID: 2244057
[TBL] [Abstract][Full Text] [Related]
17. Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain.
Montalban C; Martinez-Fernandez R; Calleja JL; Garcia-Diaz JD; Rubio R; Dronda F; Moreno S; Yebra M; Barros C; Cobo J
Rev Infect Dis; 1989; 11(4):655-60. PubMed ID: 2672242
[TBL] [Abstract][Full Text] [Related]
18. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
[TBL] [Abstract][Full Text] [Related]
19. [Kala-azar in immunosuppressed patients. Apropos of a case disclosed by skin lesions].
Frances C; Merle Beral H; Franceschini P; Lessana-Leibowitch M; Escande JP
Presse Med; 1984 Nov; 13(40):2433-6. PubMed ID: 6239222
[TBL] [Abstract][Full Text] [Related]
20. [Visceral leishmaniasis and acquired immunodeficiency syndrome].
Vallespí T; Torrabadella M; Irriguible D; Ocaña I; Martínez-Vázquez JM; Orriols R; de Gracia J; Gasser I; Portús M
Sangre (Barc); 1989 Jun; 34(3):241-3. PubMed ID: 2788313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
